EMAIL THIS PAGE TO A FRIEND

PloS one

An Aqueous Two-Phase System for the Concentration and Extraction of Proteins from the Interface for Detection Using the Lateral-Flow Immunoassay.


PMID 26556593

Abstract

The paper-based immunoassay for point-of-care diagnostics is widely used due to its low cost and portability over traditional lab-based assays. Lateral-flow immunoassay (LFA) is the most well-established paper-based assay since it is rapid and easy to use. However, the disadvantage of LFA is its lack of sensitivity in some cases where a large sample volume is required, limiting its use as a diagnostic tool. To improve the sensitivity of LFA, we previously reported on the concentration of analytes into one of the two bulk phases of an aqueous two-phase system (ATPS) prior to detection. In this study, we preserved the advantages of LFA while significantly improving upon our previous proof-of-concept studies by employing a novel approach of concentrating gold nanoparticles, a common LFA colorimetric indicator. By conjugating specific antibodies and polymers to the surfaces of the particles, these gold nanoprobes (GNPs) were able to capture target proteins in the sample and subsequently be concentrated within 10 min at the interface of an ATPS solution comprised of polyethylene glycol, potassium phosphate, and phosphate-buffered saline. These GNPs were then extracted and applied directly to LFA. By combining this prior ATPS interface extraction with LFA, the detection limit of LFA for a model protein was improved by 100-fold from 1 ng/μL to 0.01 ng/μL. Additionally, we examined the behavior of the ATPS system in fetal bovine serum and synthetic urine to more closely approach real-world applications. Despite using more complex matrices, ATPS interface extraction still improved the detection limit by 100-fold within 15 to 25 min, demonstrating the system's potential to be applied to patient samples.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA001527
Anti-TF antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA005692
Anti-TF antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
GW20009F
Anti-Transferrin antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
T2027 Anti-Transferrin antibody produced in goat, whole antiserum
B4287
Bovine Serum Albumin, heat shock fraction, protease free, suitable for hybridization, pH 7, ≥98%
145726
DL-Tyrosine, 99%
C9H11NO3
SAB1402940
Monoclonal Anti-TF antibody produced in mouse, clone 1C2, purified immunoglobulin, buffered aqueous solution
S7903
Sucrose, BioXtra, ≥99.5% (GC)
C12H22O11
84097
Sucrose, BioUltra, for molecular biology, ≥99.5% (HPLC)
C12H22O11
S9378
Sucrose, ≥99.5% (GC)
C12H22O11
S0389
Sucrose, for molecular biology, ≥99.5% (GC)
C12H22O11
S1888
Sucrose, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.5% (GC)
C12H22O11
S8501
Sucrose, ≥99.5%
C12H22O11
S5016
Sucrose, ACS reagent
C12H22O11
16104
Sucrose, puriss., meets analytical specification of Ph. Eur., BP, NF
C12H22O11
S5390
Sucrose, Grade I, plant cell culture tested
C12H22O11
S5391
Sucrose, Grade II, plant cell culture tested
C12H22O11
S3929
Sucrose, meets USP testing specifications
C12H22O11
179949
Sucrose, reagent grade
C12H22O11
47289
Sucrose, analytical standard
C12H22O11